Healthcare, where the science must survive scrutiny.
Medical accuracy, regulatory constraint and clinician sophistication set the bar. Getting the science wrong here is not a copy problem. It is a compliance problem.
In a retrospective cohort (n = 4,120), referral-to-appointment interval fell from a median of 11 days to 4 (IQR 2 to 7) after pathway consolidation. Limitations: single system, no control arm.
Patients in the two regions now wait about four days for a referral appointment instead of eleven. This is based on one health system's records over a year.
Category realities
Generic writers simplify medical mechanisms into inaccuracies. Marketing-first framing ignores clinical audience conventions. Regulatory oversight failures create liability that outlives the campaign.
A consultant physician who checks the citation, and a compliance officer who checks the claim against the label.
Frameworks the writing has to respect
Regulatory-adjacent without prescribing. Framework-aware without pretending to be counsel or a clinician.
| Framework | Jurisdiction | What it constrains in the writing |
|---|---|---|
| CDSCO, Drugs and Magic Remedies Act | India | What a health product may claim to treat, prevent or cure, and in what words. |
| DPDP Act 2023 | India | How patient data may be described, anonymised and used in case studies and research. |
| HIPAA | United States | What may be said about patients, even anonymised, and how research data is handled. |
| FDA, MHRA labelling and promotion rules | US, UK | Claims must match the label. Off-label discussion has rules. |
| Clinical citation conventions | Global | Every clinical claim traces to a citation a clinician would accept. |
| Advertising codes for health services | Per market | Testimonials, outcomes and comparison claims are constrained. |
Three pitfalls, written from work we have had to correct
A patient explainer described a mechanism in a way that was easy to read and clinically wrong. A physician commented publicly within the hour.
Anonymised in name, identifiable in detail. Pulled after a DPDP review.
A digital-health founder wrote in the marketing register about outcomes. Clinicians read it as a claim, and it was.
What we produce here
| Recommended entry | Why | Price |
|---|---|---|
| Voice Pro for the clinical leader | Two registers, cited claims, a provider-facing letter. Case 12 started here. | ₹2,49,000/mo |
| Regulatory-adjacent explainer, pillar | Framework-aware, refreshed when the rule changes. | ₹80,000 |
| Outcome benchmark report | The number clinicians and payers cite, method disclosed. Per page. | ₹17,000/page |
Two healthcare engagements.
One question we always get
Do you have clinical writers?
Bring the finding. We will write it in both registers.
The audit maps who is teaching your category today, with screenshots, and the three claims you own and have not published. Sent 48 hours before the call.
